These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21330379)

  • 1. Isorhamnetin suppresses skin cancer through direct inhibition of MEK1 and PI3-K.
    Kim JE; Lee DE; Lee KW; Son JE; Seo SK; Li J; Jung SK; Heo YS; Mottamal M; Bode AM; Dong Z; Lee HJ
    Cancer Prev Res (Phila); 2011 Apr; 4(4):582-91. PubMed ID: 21330379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The P110 subunit of PI3-K is a therapeutic target of acacetin in skin cancer.
    Jung SK; Kim JE; Lee SY; Lee MH; Byun S; Kim YA; Lim TG; Reddy K; Huang Z; Bode AM; Lee HJ; Lee KW; Dong Z
    Carcinogenesis; 2014 Jan; 35(1):123-30. PubMed ID: 23913940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine.
    Lee KW; Kang NJ; Heo YS; Rogozin EA; Pugliese A; Hwang MK; Bowden GT; Bode AM; Lee HJ; Dong Z
    Cancer Res; 2008 Feb; 68(3):946-55. PubMed ID: 18245498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delphinidin attenuates neoplastic transformation in JB6 Cl41 mouse epidermal cells by blocking Raf/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling.
    Kang NJ; Lee KW; Kwon JY; Hwang MK; Rogozin EA; Heo YS; Bode AM; Lee HJ; Dong Z
    Cancer Prev Res (Phila); 2008 Dec; 1(7):522-31. PubMed ID: 19139002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myricetin is a novel natural inhibitor of neoplastic cell transformation and MEK1.
    Lee KW; Kang NJ; Rogozin EA; Kim HG; Cho YY; Bode AM; Lee HJ; Surh YJ; Bowden GT; Dong Z
    Carcinogenesis; 2007 Sep; 28(9):1918-27. PubMed ID: 17693661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A chrysin derivative suppresses skin cancer growth by inhibiting cyclin-dependent kinases.
    Liu H; Liu K; Huang Z; Park CM; Thimmegowda NR; Jang JH; Ryoo IJ; He L; Kim SO; Oi N; Lee KW; Soung NK; Bode AM; Yang Y; Zhou X; Erikson RL; Ahn JS; Hwang J; Kim KE; Dong Z; Kim BY
    J Biol Chem; 2013 Sep; 288(36):25924-25937. PubMed ID: 23888052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taxifolin suppresses UV-induced skin carcinogenesis by targeting EGFR and PI3K.
    Oi N; Chen H; Ok Kim M; Lubet RA; Bode AM; Dong Z
    Cancer Prev Res (Phila); 2012 Sep; 5(9):1103-14. PubMed ID: 22805054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRIMA-1Met suppresses colorectal cancer independent of p53 by targeting MEK.
    Lu T; Zou Y; Xu G; Potter JA; Taylor GL; Duan Q; Yang Q; Xiong H; Qiu H; Ye D; Zhang P; Yu S; Yuan X; Zhu F; Wang Y; Xiong H
    Oncotarget; 2016 Dec; 7(50):83017-83030. PubMed ID: 27806324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CInQ-03, a novel allosteric MEK inhibitor, suppresses cancer growth in vitro and in vivo.
    Kim DJ; Lee MH; Reddy K; Li Y; Lim DY; Xie H; Lee SY; Yeom YI; Bode AM; Dong Z
    Carcinogenesis; 2013 May; 34(5):1134-43. PubMed ID: 23354306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effects of novel highly hydrophilic and non-ATP-competitive MEK1/2 inhibitor, SMK-17.
    Kiga M; Tanzawa F; Iwasaki S; Inaba F; Fujiwara K; Iwadare H; Echigo T; Nakamura Y; Shibata T; Suzuki K; Yasumatsu I; Nakayama A; Sasazawa Y; Tashiro E; Imoto M; Kurakata S
    Anticancer Drugs; 2012 Jan; 23(1):119-30. PubMed ID: 22008853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma.
    Mohan S; Vander Broek R; Shah S; Eytan DF; Pierce ML; Carlson SG; Coupar JF; Zhang J; Cheng H; Chen Z; Van Waes C
    Clin Cancer Res; 2015 Sep; 21(17):3946-56. PubMed ID: 25977343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isorhamnetin inhibits cell proliferation and induces apoptosis in breast cancer via Akt and mitogen‑activated protein kinase kinase signaling pathways.
    Hu S; Huang L; Meng L; Sun H; Zhang W; Xu Y
    Mol Med Rep; 2015 Nov; 12(5):6745-51. PubMed ID: 26502751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equol, a metabolite of the soybean isoflavone daidzein, inhibits neoplastic cell transformation by targeting the MEK/ERK/p90RSK/activator protein-1 pathway.
    Kang NJ; Lee KW; Rogozin EA; Cho YY; Heo YS; Bode AM; Lee HJ; Dong Z
    J Biol Chem; 2007 Nov; 282(45):32856-66. PubMed ID: 17724030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isorhamnetin suppresses colon cancer cell growth through the PI3K‑Akt‑mTOR pathway.
    Li C; Yang X; Chen C; Cai S; Hu J
    Mol Med Rep; 2014 Mar; 9(3):935-40. PubMed ID: 24398569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-deoxykaempferol plays a potential therapeutic role by targeting multiple signaling pathways in skin cancer.
    Lee KM; Lee KW; Byun S; Jung SK; Seo SK; Heo YS; Bode AM; Lee HJ; Dong Z
    Cancer Prev Res (Phila); 2010 Apr; 3(4):454-65. PubMed ID: 20233901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the MEK-S6 pathway in high-grade ovarian cancers.
    Ventura AP; Radhakrishnan S; Green A; Rajaram SK; Allen AN; O'Briant K; Schummer M; Karlan B; Urban N; Tewari M; Drescher C; Knudsen BS
    Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):499-508. PubMed ID: 20661131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bakuchiol suppresses proliferation of skin cancer cells by directly targeting Hck, Blk, and p38 MAP kinase.
    Kim JE; Kim JH; Lee Y; Yang H; Heo YS; Bode AM; Lee KW; Dong Z
    Oncotarget; 2016 Mar; 7(12):14616-27. PubMed ID: 26910280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of 4-anilino-3-quinolinecarbonitrile inhibitors of mitogen-activated protein/extracellular signal-regulated kinase 1 kinase.
    Mallon R; Feldberg L; Kim S; Collins K; Wojciechowicz D; Kohler C; Kovacs D; Discafani C; Zhang N; Wu B; Floyd B; Powell D; Berger D
    Mol Cancer Ther; 2004 Jun; 3(6):755-62. PubMed ID: 15210862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling.
    Ding J; Wen W; Xiang D; Yin P; Liu Y; Liu C; He G; Cheng Z; Yin J; Sheng C; Zhang W; Nan F; Ye W; Zhang X; Wang H
    Oncotarget; 2015 May; 6(13):11627-39. PubMed ID: 25890498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Licochalcone A, a polyphenol present in licorice, suppresses UV-induced COX-2 expression by targeting PI3K, MEK1, and B-Raf.
    Song NR; Kim JE; Park JS; Kim JR; Kang H; Lee E; Kang YG; Son JE; Seo SG; Heo YS; Lee KW
    Int J Mol Sci; 2015 Feb; 16(3):4453-70. PubMed ID: 25710724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.